Regulatory Timelines

From approval to reimbursement, measured.

Approval dates across nine authorities, FDA to MFDS, joined by molecule to 23,196 HTA decisions across sixteen systems. Regulators decide whether a medicine may be sold. HTA bodies decide whether a health system will pay for it. The gap between the two is the number every launch plan needs and almost nobody measures. Two worked examples are free below; the full layer is in the subscription.

4,691molecules
9authorities · US · EU · UK · CA · AU · CH · BR · JP · KR
1,873linked to HTA decisions
16HTA systems

The lag table

Median days from EMA authorisation to each agency's first published decision on the same molecule. Computed from the joined records, not surveyed. Four rows are open; subscribers see all sixteen systems, every molecule behind each median, and the timelines for the US, Japan, the UK, Switzerland, Canada and Australia.

AgencyMedian lagMolecules
HAS · France223 days413
G-BA · Germany268 days345
TLV · Swedensubscriber data460
SMC · Scotlandsubscriber data595
NICE · England405 days355
AIFA · Italysubscriber data173
Medicinrådet · Denmarksubscriber data192
CIPM · Spainsubscriber data266
Nye Metoder · Norwaysubscriber data229
AOTMiT · Poland875 days251

Two molecules, end to end

The same two worked examples as our HTA tool. Every dot is a dated primary record.

The full layer is one subscription away

Every molecule, every authority, every lag, in the portal and over the API.

See pricing